SCHEMBL1116164

SCHEMBL1116164

COc1ccc(-c2ccc(C=C3N=C(N)NC3=O)o2)c(OC)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 4/20 0.60
▸ CA2 P00918 2/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CLK1 P49759 1/20 0.48
▸ CLK2 P49760 1/20 0.48
▸ CLK4 Q9HAZ1 1/20 0.48
▸ GSK3B P49841 1/20 0.44
▸ PIK3CG P48736 2/20 0.43
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ POLB P06746 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ RECQL P46063 2/20 0.39
▸ F5 P12259 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ GFER P55789 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116160 1.00 HTR2A (0.60) HTR2ACA2CA1CLK1CLK2
SCHEMBL12899354 0.89 HTR2A (0.50) HTR2ACA2CA1CLK1CLK2
SCHEMBL1116262 0.83 HTR2A (0.54) HTR2ACA2CA1CLK1CLK2
SCHEMBL1116264 0.83 HTR2A (0.54) HTR2ACA2CA1CLK1CLK2
SCHEMBL1116039 0.80 MAPT (0.41) CLK1CLK2CLK4GSK3BPIK3CG
SCHEMBL1116038 0.80 MAPT (0.41) CLK1CLK2CLK4GSK3BPIK3CG
SCHEMBL1116029 0.79 PIK3CG (0.49) HTR2ACA2CA1CLK1CLK2
SCHEMBL1116026 0.79 PIK3CG (0.49) HTR2ACA2CA1CLK1CLK2
SCHEMBL6858716 0.79 PIK3CG (0.49) HTR2ACA2CA1CLK1CLK2
SCHEMBL1116040 0.78 HTR2A (0.51) HTR2ACA2CA1CLK1CLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback